1. Home
  2. PAR vs AGMB Comparison

PAR vs AGMB Comparison

Compare PAR & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$16.67

Market Cap

640.6M

Sector

Miscellaneous

ML Signal

HOLD

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$13.30

Market Cap

562.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAR
AGMB
Founded
1968
2017
Country
United States
Belgium
Employees
N/A
62
Industry
Office Equipment/Supplies/Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
640.6M
562.4M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
PAR
AGMB
Price
$16.67
$13.30
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$33.20
$32.00
AVG Volume (30 Days)
1.3M
98.9K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$455,547,000.00
N/A
Revenue This Year
$9.82
N/A
Revenue Next Year
$11.27
$17.86
P/E Ratio
N/A
N/A
Revenue Growth
30.16
N/A
52 Week Low
$11.59
$8.75
52 Week High
$72.15
$17.45

Technical Indicators

Market Signals
Indicator
PAR
AGMB
Relative Strength Index (RSI) 61.80 64.12
Support Level $12.50 $9.54
Resistance Level $22.48 $14.19
Average True Range (ATR) 0.96 1.17
MACD 0.21 0.36
Stochastic Oscillator 92.84 81.52

Price Performance

Historical Comparison
PAR
AGMB

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). Its product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: